Ultralife closed at $15.63 on Nov 5, up 0.06% — matching its 52-week closing high. Volume of 242.4K shares was 0.89× its 20-day average (close to normal).
Split-adjusted performance: +145.8% over one month, +121.7% over six months, +127.8% over one year.
In the quarter ended Jun 30, 2026, revenue was $47.94M, down 1.3% from a year earlier, with a net margin of 5.3%.
Short interest was 89.8K shares at the Oct 15 settlement, down 11.9% from the prior report (1.0% of float, 3.9 days to cover).